XENON PHARMACEUTICALS INC (XENE:NASDAQ)
$58.97 0.17 (0.2891%)
Analysed XENON PHARMACEUTICALS INC (XENE:NASDAQ) News Sources
Xenon to Report Q2 2026 Financial Results on August 6, 2026
30-07-2026
yahoo.com
Xenon Reports Q2 2026 Financial Results and Provides Business Update
06-08-2026
yahoo.com
Xenon Pharmaceuticals Inc (XENE) (Q2 2026) Earnings Call Highlights: Advancing Azetukalner ...
07-08-2026
yahoo.com
Xenon Pharmaceuticals' Azetukalner NDA Filing Remains on Track After FDA Meeting, RBC Says
07-08-2026
yahoo.com
Major Depressive Disorder Market is Predicted to Grow During the Forecast Period (2026-2036) as Novel Antidepressants are Expected to Enter the Market | DelveInsight
10-08-2026
yahoo.com
Xenon Pharmaceuticals (XENE) Q2 2026 Earnings Call Transcript
13-08-2026
fool.com
Xenon to Highlight Phase 3 X-TOLE2 Clinical Data and Rational Polytherapy Potential for Azetukalner at EEC 2026
26-08-2026
yahoo.com
What Xenon Pharmaceuticals (XENE)'s New Azetukalner Phase 3 Epilepsy Data Means For Shareholders
28-08-2026
yahoo.com
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
28-08-2026
yahoo.com
Xenon (XENE) Heads To Europe With Data That Could Reshape Epilepsy Care
04-09-2026
yahoo.com
What is the current price of XENON PHARMACEUTICALS INC (XENE:NASDAQ)?
The current price of XENON PHARMACEUTICALS INC (XENE:NASDAQ) is $58.97.
XENON PHARMACEUTICALS INC (XENE:NASDAQ) absolute price change since previous trading day?
The absolute price change of XENON PHARMACEUTICALS INC (XENE:NASDAQ) since the previous trading day is $0.17.
XENON PHARMACEUTICALS INC (XENE:NASDAQ) percentage price change since previous trading day?
The percentage price change of XENON PHARMACEUTICALS INC (XENE:NASDAQ) since the previous trading day is 0.2891%.
What is the most recent average sentiment score for XENON PHARMACEUTICALS INC (XENE:NASDAQ)?
The most recent average sentiment score for XENON PHARMACEUTICALS INC (XENE:NASDAQ) is 74 out of 100.
What is the most recent average sentiment for XENON PHARMACEUTICALS INC (XENE:NASDAQ)?
The most recent sentiment for XENON PHARMACEUTICALS INC (XENE:NASDAQ) is .
SEC-8K** Filing Available For XENON PHARMACEUTICALS INC (XENE:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.